DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹13,034 Cr | ₹9,588 Cr | ₹8,572 Cr | ₹9,766 Cr | ₹8,104 Cr |
What is the latest Total Current Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹13,034 Cr |
| Mar2024 | ₹9,588 Cr |
| Mar2023 | ₹8,572 Cr |
| Mar2022 | ₹9,766 Cr |
| Mar2021 | ₹8,104 Cr |
How is Total Current Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,034 Cr | 35.94 | |
| Mar2024 | ₹9,588 Cr | 11.85 | |
| Mar2023 | ₹8,572 Cr | -12.22 | |
| Mar2022 | ₹9,766 Cr | 20.51 | |
| Mar2021 | ₹8,104 Cr | - | |
Compare Total Current Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹114,879.8 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| MANKIND PHARMA | ₹102,642.0 Cr | -2% | 2.7% | 7.5% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 6.6% |
4.3% |
1.9% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses